A Study to Compare Pharmacokinetic and Safety of TRS003 to China-approved Bevacizumab and US-licensed Avastin®
Clinical trial NCT03882424 · COMPLETED
Trial details
- NCT number
- NCT03882424
- Sponsor
- Zhejiang Teruisi Pharmaceutical Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-12
- Primary completion
- 2018-09-30
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.